NanoRepro AG
Develops and distributes rapid diagnostic self-tests for early disease detection.
NN6 | F
Overview
Corporate Details
- ISIN(s):
- DE0006577109
- LEI:
- 3912008FCA63AGIMEV74
- Country:
- Germany
- Address:
- UNTERGASSE 8, 35037 MARBURG
- Website:
- https://www.nanorepro.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
NanoRepro AG is an innovative leader in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The company serves both home and professional markets, domestically and internationally. Its product portfolio is designed to provide rapid and accurate results for early disease detection and preventive healthcare. Key product categories include family planning, disease detection, food intolerances, allergies, and infectious diseases. The company's stated goal is to provide accuracy in self-diagnostics for rapid disease detection.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-05 22:30 |
Pre-Annual General Meeting Information
NanoRepro AG: Einberufungsverlangen fur eine auerordentliche Hauptversammlung z…
|
German | 10.6 KB | ||
| 2025-10-31 12:00 |
Earnings Release
NanoRepro AG: Halbjahreszahlen 2025 - NanoRepro setzt Wachstumskurs fort
|
German | 16.4 KB | ||
| 2025-09-05 00:00 |
Annual Report
Datum:05.09.2025
|
German | 442.2 KB | ||
| 2025-08-20 14:30 |
Regulatory Filings
NanoRepro AG: Aktuelle GBC-Studie mit Kursziel 4,50 Euro
|
German | 13.2 KB | ||
| 2025-08-05 14:00 |
Director's Dealing
NanoRepro AG: Lisa Jungst, buy
|
German | 6.0 KB | ||
| 2025-07-21 00:00 |
Annual / Quarterly Financial Statement
Berichtigung der Veröffentlichung vom 14.03.2025
|
German | 15.0 KB | ||
| 2025-07-18 15:00 |
Earnings Release
NanoRepro AG: Endgultige Jahreszahlen 2024 - NanoRepro bleibt auf Wachstumskurs
|
German | 14.4 KB | ||
| 2025-05-26 14:01 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | ||
| 2025-05-19 12:01 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 6.0 KB | ||
| 2025-05-08 15:01 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 5.9 KB | ||
| 2025-04-29 14:00 |
M&A Activity
NanoRepro AG: NanoRepro AG investiert in Kaltplasma-Technologie und baut ihre M…
|
German | 11.4 KB | ||
| 2025-04-16 14:00 |
Regulatory Filings
NanoRepro AG: NanoRepro erhalt EU-Qualitatsmanagementbescheinigung nach Verordn…
|
German | 8.9 KB | ||
| 2025-03-27 15:46 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 5.9 KB | ||
| 2025-03-26 16:01 |
Director's Dealing
NanoRepro AG: Dr. Olaf Stiller, buy
|
German | 5.9 KB | ||
| 2025-03-14 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
|
German | 34.7 KB |
Automate Your Workflow. Get a real-time feed of all NanoRepro AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NanoRepro AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NanoRepro AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-25 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 14,506.24 EUR |
| 2025-02-17 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 18,750.00 EUR |
| 2024-10-29 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 17,300.00 EUR |
| 2024-10-22 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 8,949.96 EUR |
| 2024-10-22 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 8,500.00 EUR |
| 2024-10-21 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 8,750.00 EUR |
| 2024-10-21 | Stiller, Johanna | Close relation | Buy | None | 3,759.00 EUR |
| 2024-08-30 | ASS GmbH | Close relation | Buy | None | 30,644.30 EUR |
| 2024-07-25 | Stiller, Dr. Olaf | Supervisory board | Buy | None | 3,279.18 EUR |
| 2024-07-24 | Jüngst, Lisa | Board | Buy | None | 21,762.00 EUR |
Peer Companies
